中国全科医学 ›› 2027, Vol. 30 ›› Issue (01): 91-97.DOI: 10.12114/j.issn.1007-9572.2026.0120

• 论著 • 上一篇    

温和灸改善乳腺癌淋巴水肿及其证候表型的多中心临床效果研究

金咏梅1, 袁计红1,*(), 邱霖2, 宋莉芳1, 吴雅妮3, 姜娜娜4   

  1. 1.200137 上海市,上海中医药大学附属第七人民医院护理部
    2.201203 上海市,上海中医药大学研究生院
    3.200433 上海市,海军军医大学第一附属医院乳腺外科
    4.200120 上海市,同济大学附属东方医院甲乳外科
  • 收稿日期:2026-03-25 修回日期:2026-06-18 出版日期:2027-01-05 发布日期:2026-11-17
  • 通讯作者: 袁计红

  • 作者贡献:

    金咏梅提出主要研究目标,负责研究构思与设计、文章的质量控制与审查;袁计红负责数据整理、统计学处理,撰写论文;邱霖、宋莉芳、吴雅妮、姜娜娜进行数据的收集与整理、表格的绘制与展示。

  • 基金资助:
    上海市浦东新区卫生健康委员会面上项目(PW2023A-15); 2022年浦东新区卫生健康委员会学科建设计划(PWZxk2022-06)

Observation on the Multi-center Clinical Effect of Mild Moxibustion on Improving Breast Cancer Related-lymphoedema and Its Symptom Phenotype

JIN Yongmei1, YUAN Jihong1,*(), QIU Lin2, SONG Lifang1, WU Yani3, JIANG Nana4   

  1. 1. Department of Nursing, Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China
    2. Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    3. Department of Breast Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
    4. Department of Thyroid and Breast Surgery, Tongji University East Hospital, Shanghai 200120, China
  • Received:2026-03-25 Revised:2026-06-18 Published:2027-01-05 Online:2026-11-17
  • Contact: YUAN Jihong

摘要: 背景 乳腺癌已取代肺癌居于全球新发癌症的首位,乳腺癌相关淋巴水肿是乳腺癌术后最常见的并发症之一,但关于不同证型乳腺癌患者发生淋巴水肿分布规律的研究较少。 目的 评价温和灸对乳腺癌淋巴水肿的临床效果,明确患者中医证候表型分布规律,为临床制定标准化防治方案提供循证依据。 方法 采用多中心、随机、平行对照试验设计,选取2023年10月—2024年9月在上海市第七人民医院、海军军医大学第一附属医院、上海市东方医院普外科确诊为乳腺癌淋巴水肿的226例患者为研究对象,按1∶1随机化分配至干预组和对照组,每组113例。对照组给予常规预防干预,干预组在对照组基础上行温和灸治疗,干预周期3个月,随访12个月。比较干预前后主要结局指标[上臂周径最大差值、局部组织水分比(LTW)、淋巴水肿进展率]、次要结局指标[乳腺癌淋巴水肿症状指数(BCLE-SEI)、乳腺癌生命质量测定量表(FACT-B)]及证候表型分布情况。 结果 本研究最终完成219例,干预组110例、对照组109例,总脱落率3.10%。干预前,两组患者以气血两虚证87例(39.73%)、气滞痰凝证63例(28.76%)、瘀毒互结证41例(18.72%)为主要证候类型,占总病例数的87.21%。组别与时间对上臂周径最大差值、LTW、BCLE-SEI、FACT-B均存在交互作用(P交互<0.001),两者主效应显著(P<0.001)。干预前两组上述指标比较,差异均无统计学意义(P>0.05);干预后,干预组上臂周径最大差值、LTW、BCLE-SEI均低于对照组,FACT-B高于对照组,差异有统计学意义(P<0.05)。组内比较显示,干预后两组上臂周径最大差值、LTW、BCLE-SEI均低于本组干预前,且干预后6、9、12个月低于本组干预后3个月(P<0.05);干预后两组FACT-B高于本组干预前,且干预后6、9、12个月高于本组干预后3个月,差异均有统计学意义(P<0.05)。随访12个月,干预组淋巴水肿进展率低于对照组,差异有统计学意义(P=0.009)。两组患者以气血两虚证57例(26.03%)、气滞痰凝证43例(19.63%)、冲任失调证38例(17.35%)为主要证候类型,占总病例数的63.01%;对照组气血两虚证、气滞痰凝证占比高于干预组,干预组冲任失调证、气阴两虚证、毒热蕴结证占比高于对照组,差异均有统计学意义(P<0.05)。两组不良事件发生率比较,差异无统计学意义(P>0.05)。 结论 乳腺癌淋巴水肿患者存在特征性中医证候分布规律,以气血两虚证、气滞痰凝证、瘀毒互结证为核心证型,温和灸可有效调节患者证候表型,为临床开展乳腺癌淋巴水肿中医辨证施护提供精准理论依据。

关键词: 乳腺癌, 淋巴水肿, 证候表型, 温和灸, 多中心研究

Abstract:

Background

Breast cancer has surpassed lung cancer to become the most prevalent newly diagnosed cancer worldwide. Breast cancer-related lymphedema (BCRL) is one of the most common postoperative complications of breast cancer; however, studies on the distribution patterns of traditional Chinese medicine (TCM) syndromes in patients with BCRL remain limited.

Objective

To evaluate the clinical efficacy of mild moxibustion on the progression of BCRL, clarify the distribution patterns of TCM syndrome types in affected patients, and provide evidence-based support for the development of standardized clinical prevention and management strategies.

Methods

A multicenter, randomized, parallel-controlled trial was conducted. A total of 226 patients diagnosed with breast cancer lymphedema at the Department of General Surgery of Shanghai Seventh People's Hospital, the First Affiliated Hospital of Naval Medical University, or Shanghai East Hospital between October 2023 and September 2024 were enrolled as study subjects. They were randomly assigned in a 1∶1 ratio to either the intervention group or the control group, with 113 cases in each group. The control group received routine preventive interventions, while the intervention group received mild moxibustion in addition to routine care. The intervention period lasted 3 months, with a follow-up duration of 12 months. Comparison of primary outcome indicators including maximum difference in upper arm circumference, local tissue water ratio (LTW), progression rate of lymphedema, and secondary outcome indicators including Breast Cancer Lymphedema Symptom Index (BCLE-SEI), the Functional Assessment of Cancer Therapy-Breast (FACT-B), and symptom phenotype distribution before and after intervention.

Results

A total of 219 patients completed the trial, including 110 in the intervention group and 109 in the control group, yielding an overall dropout rate of 3.10%. At baseline, the predominant traditional Chinese medicine (TCM) syndromes were dual deficiency of qi and blood (87 cases, 39.73%), qi stagnation and phlegm coagulation (63 cases, 28.76%), and intermingled blood stasis and toxin (41 cases, 18.72%), together accounting for 87.21% of all enrolled patients. There were significant group-by-time interaction effects for the maximum difference in upper arm circumference, LTW, BCLE-SEI and FACT-B (Pinteraction<0.001), and both main effects were significant (P<0.001). No significant between-group differences in these indicators were observed at baseline (P>0.05). After intervention, the maximum difference in upper arm circumference, LTW and BCLE-SEI of the intervention group were lower than the control group, while FACT-B was higher than the control group, with statistically significant differences (P<0.05). Intra-group comparison showed that the maximum difference in upper arm circumference, LTW and BCLE-SEI of both groups after intervention were lower than those before intervention; the values at 6, 9 and 12 months after intervention were lower than those at 3 months after intervention (P<0.05); FACT-B of both groups after intervention was higher than that before intervention, avalues at 6, 9 and 12 months after intervention were higher than those at 3 months after intervention, with statistically significant differences (P<0.05). At the 12-month follow-up, the intervention group had a lower lymphedema progression rate than the control group (P=0.009). Post-intervention, the predominant syndromes shifted to dual deficiency of qi and blood (57 cases, 26.03%), qi stagnation and phlegm coagulation (43 cases, 19.63%), and thoroughfare-conception vessel disorder (38 cases, 17.35%), collectively accounting for 63.01% of the total patients. The proportions of dual deficiency of qi and blood, qi stagnation and phlegm coagulation in the control group were higher than those in the intervention group, while the proportions of thoroughfare-conception vessel disorder, dual deficiency of qi and yin, and toxin-heat accumulation syndrome in the intervention group were higher than those in the control group, with statistically significant differences (P<0.05). There was no statistically significant difference in the incidence of adverse events between the two groups (P>0.05).

Conclusion

Patients with BCRL exhibit characteristic distribution patterns of TCM syndrome phenotypes, with syndrome of dual deficiency of qi and blood, syndrome of qi stagnation and phlegm coagulation, and syndrome of intermingled blood stasis and toxin as the core syndrome types. Mild moxibustion can effectively regulate syndrome phenotypes in these patients, thereby providing a precise theoretical basis for TCM syndrome differentiation-based nursing and management of BCRL in clinical practice.

Key words: Breast cancer, Lymphedema, Syndrome phenotype, Mild moxibustion, Multicenter study